| 000 | 01115 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515201306.0 | ||
| 264 | 0 | _c20100826 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1573-7209 | ||
| 024 | 7 |
_a10.1007/s10456-009-9160-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGotink, Kristy J | |
| 245 | 0 | 0 |
_aAnti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? _h[electronic resource] |
| 260 |
_bAngiogenesis _cMar 2010 |
||
| 300 |
_a1-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aVerheul, Henk M W | |
| 773 | 0 |
_tAngiogenesis _gvol. 13 _gno. 1 _gp. 1-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10456-009-9160-6 _zAvailable from publisher's website |
| 999 |
_c19393954 _d19393954 |
||